» Articles » PMID: 1649338

Absence of Asparagine-linked Oligosaccharides from Glycoprotein D of Herpes Simplex Virus Type 1 Results in a Structurally Altered but Biologically Active Protein

Overview
Journal J Virol
Date 1991 Aug 1
PMID 1649338
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Glycoprotein D (gD) of herpes simplex virus contains three utilized sites (Asn-X-Ser/Thr) for addition of asparagine-linked carbohydrates (N-CHO). Previously, we used oligonucleotide-directed mutagenesis to alter serine or threonine residues to alanine at each N-CHO addition site. Studies with monoclonal antibodies showed that a mutant protein lacking all three sites (now designated AAA) was structurally altered because of the amino acid change at residue 96 as well as the absence of the N-CHO. In this study, we constructed additional single mutations at site 1 (residues 94 and 96) and found that in most cases, the amino acid change itself adversely affected the conformation of gD. However, changing asparagine 94 to glutamine (Q) at site 1 had the least effect on gD. We constructed a second triple mutant, QAA, which lacked all three N-CHO signals. The antigenic conformation of QAA was similar to that of gD produced in the presence of tunicamycin (TM-gD). However, binding of MAbs to the AAA protein or to single mutants altered at site 1 was reduced compared with TM-gD. Wild-type gD and QAA proteins were equally susceptible to digestion by trypsin or Staphylococcus aureus V8 protease. In contrast, the AAA protein was more sensitive to trypsin but less sensitive to V8, again suggesting conformational alterations of the AAA protein. Despite what appeared to be large changes in structure, each mutant complemented the infectivity of a virus lacking gD (F-gD beta). We conclude that the N-CHO and amino acids at N-CHO site 1 play an important role in forming and/or maintaining gD structure, but none of the N-CHO are required for gD to function in the complementation assay.

Citing Articles

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy.

Atanasiu D, Saw W, Friedman H, Cohen G Viruses. 2025; 17(2).

PMID: 40007004 PMC: 11860751. DOI: 10.3390/v17020249.


Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate.

Gandy L, Canning A, Lou H, Xia K, He P, Su G Front Mol Biosci. 2022; 9:1043713.

PMID: 36419932 PMC: 9678342. DOI: 10.3389/fmolb.2022.1043713.


Influence of N-glycosylation on Expression and Function of Pseudorabies Virus Glycoprotein gB.

Vallbracht M, Klupp B, Mettenleiter T Pathogens. 2021; 10(1).

PMID: 33445487 PMC: 7827564. DOI: 10.3390/pathogens10010061.


Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction.

Lu H, Cherepanova N, Gilmore R, Contessa J, Lehrman M FASEB J. 2019; 33(6):6801-6812.

PMID: 30811219 PMC: 6529348. DOI: 10.1096/fj.201802044RR.


Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.

Atanasiu D, Saw W, Lazear E, Whitbeck J, Cairns T, Lou H J Virol. 2018; 92(24).

PMID: 30282715 PMC: 6258950. DOI: 10.1128/JVI.01694-18.


References
1.
Muggeridge M, Wu T, Johnson D, Glorioso J, Eisenberg R, Cohen G . Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology. 1990; 174(2):375-87. DOI: 10.1016/0042-6822(90)90091-5. View

2.
Feenstra V, Hodaie M, Johnson D . Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains. J Virol. 1990; 64(5):2096-102. PMC: 249366. DOI: 10.1128/JVI.64.5.2096-2102.1990. View

3.
Watson R, Weis J, Salstrom J, Enquist L . Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli. Science. 1982; 218(4570):381-4. DOI: 10.1126/science.6289440. View

4.
Svennerholm B, Olofsson S, Lunden R, Vahlne A, LYCKE E . Adsorption and penetration of enveloped herpes simplex virus particles modified by tunicamycin or 2-deoxy-D-glucose. J Gen Virol. 1982; 63(2):343-9. DOI: 10.1099/0022-1317-63-2-343. View

5.
Gorman C, Moffat L, Howard B . Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982; 2(9):1044-51. PMC: 369897. DOI: 10.1128/mcb.2.9.1044-1051.1982. View